lactic acid has been researched along with vorinostat in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ravikumar, V; Sankar, R | 2 |
| Karthik, S; Krishnaswami, V; Ravikumar, V; Sankar, R; Sonnemann, J; Subramanian, N | 1 |
| Jeong, YI; Kang, DH; Kim, C; Kim, J; Kwak, TW; Lee, HL; Seo, SJ; Song, YH | 1 |
5 other study(ies) available for lactic acid and vorinostat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Drug Delivery Systems; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lactic Acid; Male; Mice; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Tissue Distribution; Vorinostat | 2014 |
Nanostructured delivery system for Suberoylanilide hydroxamic acid against lung cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Diffusion; Drug Synergism; Humans; Hydroxamic Acids; Lactic Acid; Lung Neoplasms; Materials Testing; Nanocapsules; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Vorinostat | 2015 |
Preparation of Histone Deacetylase Inhibitor Vorinostat-Loaded Poly D, L-Lactide-co-Glycolide Polymeric Nanoparticles by Nanoprecipitation Method.
Topics: Drug Compounding; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysorbates; Solutions; Surface-Active Agents; Vorinostat | 2017 |
Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells.
Topics: Animals; Antineoplastic Agents; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Drug Delivery Systems; Drug Liberation; Drug-Eluting Stents; Humans; Hydroxamic Acids; Lactic Acid; Mice, Nude; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vorinostat; Xenograft Model Antitumor Assays | 2017 |